The Sexual Wellness Protocol
A three-layer protocol addressing sexual wellness from the ground up: Zinc builds the hormonal foundation; PT-141 activates central arousal pathways via melanocortin receptors; Oxytocin deepens emotional connection and amplifies the bonding dimension of intimacy. The only evidence-backed supplement stack that addresses both the physiological and psychological dimensions of sexual function simultaneously.
Daily Schedule
Timing and dosage for each step
Daily (evening)
30 mg
30mg Zinc Bisglycinate with dinner - daily foundational supplementation. Optimises testosterone and gonadal function as the hormonal baseline. Start this 2-4 weeks before PT-141 use for best results.
T-60 min (before activity)
1 mg
1mg subcutaneous injection 45-60 minutes before intended sexual activity. Start at 0.5mg on first use to assess nausea tolerance. Do NOT combine with Viagra, Cialis, or any PDE5 inhibitor.
T-15 min (before activity)
40 mcg
20-40 IU intranasal spray (1-2 puffs per nostril) approximately 15-20 minutes before sexual activity. Enhances emotional connection and bonding alongside PT-141's arousal effect.
Protocol Architecture
Most sexual wellness approaches target a single mechanism. This protocol addresses three distinct layers:
Layer 1 — Hormonal Foundation (Zinc, daily) Zinc is the rate-limiting mineral for testosterone synthesis. Deficiency -- extremely common in Western diets -- directly reduces gonadal function, libido, and sexual response in both men and women. Correcting deficiency creates the hormonal environment within which the other compounds operate most effectively. Start zinc supplementation 2-4 weeks before using PT-141 and oxytocin.
Layer 2 — Central Arousal (PT-141, on-demand) PT-141 (Bremelanotide) activates melanocortin receptors (MC3R, MC4R) in the hypothalamus and limbic system -- the neural circuits responsible for generating sexual desire. Unlike PDE5 inhibitors which improve peripheral blood flow without affecting desire, PT-141 creates the neurological state of arousal and motivation. Works in both men and women. The active ingredient in FDA-approved Vyleesi.
Layer 3 — Emotional Connection (Oxytocin, on-demand) Oxytocin enhances bonding, trust, and the emotional quality of intimate experience. It reduces amygdala-mediated social threat responses and increases dopamine release in the reward pathway during intimacy. PT-141 and Oxytocin are complementary: PT-141 generates desire; Oxytocin deepens the connection.
Timing Protocol
Daily (ongoing): Zinc Bisglycinate 30mg with dinner
On the day of use:
- T-60 min: PT-141 1mg subcutaneous injection
- T-15 min: Oxytocin 20-40 IU intranasal
PT-141 reaches peak concentration approximately 45-60 minutes after injection and effects persist for 6-12 hours. Do not re-dose within 72 hours.
Critical Safety Note: PT-141 and PDE5 Inhibitors
Do not combine PT-141 with Viagra (Sildenafil), Cialis (Tadalafil), Levitra (Vardenafil), or any PDE5 inhibitor. Both compounds lower blood pressure through different mechanisms, and the combination can cause significant hypotension. This is a formal contraindication on the FDA Vyleesi label.
Nausea Management
Nausea is the most common PT-141 side effect (30-40% of users, typically mild). Strategies to reduce it:
- Start at 0.5mg for first use, titrate to 1mg if well-tolerated
- Take 4mg ondansetron (Zofran) 30 minutes before PT-141 injection
- Maintain light food intake in the 2 hours before administration
- Stay well hydrated
Who This Protocol Is For
- Individuals experiencing reduced libido or sexual desire (both men and women)
- Couples seeking to enhance intimacy and emotional connection
- Men experiencing psychogenic erectile dysfunction (where desire, not mechanics, is the primary issue)
- Women with hypoactive sexual desire disorder (HSDD) -- the primary FDA-approved indication for bremelanotide
Research Peptide Notice
PT-141 and Oxytocin in research peptide form are not the FDA-approved pharmaceutical products. For educational purposes only.